Sunday, 28 December 2025

Pentraxin 3: A Multifaceted Mediator of Inflammation and Cardiovascular Risk | Chapter 1 | Medical Science: Updates and Prospects Vol. 3

 

Introduction: Pentraxin 3 (PTX3) is an acute-phase protein that stands at the intersection between inflammation and cardiovascular pathology. Influential role of PTX3 impacts vascular inflammation, endothelial function and atherosclerotic progression. Pentraxin vascular health is staged by its dual role as a biochemical marker and a potential modulator that provides greater specificity than systemic C-reactive protein. Data synthesised positions pentraxin as a promising candidate for precision cardiovascular medicine.  PTX3 is a long pentraxin produced by stromal and myeloid cells in response to inflammatory signals and microbial moieties. It plays a multifunctional role in inflammation, acting as a functional ancestor of antibodies.

 

Objective: This review explores the relationship between PTX3 and cardiovascular risk, its diagnostic and prognostic value, and its implications for clinical practice. The objectives focused on in this chapter are the functional role of PTX3 to stratify patients according to the severity of cardiovascular risk. Secondly, the prognostic role of elevated PTX3 levels speaks about the worst outcome in patients with cardiovascular disease. Thirdly, PTX3 can be considered as a therapeutic target that reinforces new avenues of treatment.

 

Methodology: This book chapter is an outcome of a comprehensive literature review that focused on articles from the PubMed database, Scopus and Web of Science databases. Utilised the keywords such as pentraxin 3, cardiovascular disease, atherosclerosis, and inflammation. Through a reductionist approach, mechanistic insights with regard to the association between pentraxin and cardiovascular health were framed.

 

Conclusion: PTX3 is a promising biomarker for cardiovascular risk assessment and disease progression. Further research is needed to establish standardised reference values and explore its potential as a therapeutic target.

 

 

Author(s) Details

K. A. Arul Senghor
SRM Medical College Hospital & Research Centre, India.

 

V. M. Vinodhini
SRM Medical College Hospital & Research Centre, India.

 

Renuka. P
SRM Medical College Hospital & Research Centre, India.

 

M S. Vyshnavi
SRM Medical College Hospital & Research Centre, India.

 

Please see the book here :- https://doi.org/10.9734/bpi/msup/v3/6784

No comments:

Post a Comment